6515--LIAISON XL ANALYZER
Veterans Affairs · 262-NETWORK CONTRACT OFFICE 22 (36C262)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C26225Q1188 in this department, oldest first.
- Jul 14, 2025 · this noticeSources Sought
- Aug 11, 2025Award NoticeDIASORIN INC · $90KOpen
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
36C26225Q1188 NOTICE OF INTENT TO SOLE SOURCE The Department of Veterans Affairs, Network Contracting Office (NCO) 22, located at 4811 Airport Plaza Drive, Long Beach, CA 90815 is issuing this Notice of Intent (NOI) to inform industry contractors of the Government s intent to execute a Sole Source Award under FAR Part 13 Simplified Acquisition Procedures (SAP), specifically FAR Subpart 13.5 Simplified Procedures for Certain Commercial Items. The intended Contractor is Diasorin, Inc., a large business, headquartered at 1951 Northwestern Ave S Stillwater, MN. 55082 VISN 22 site PhoenixVA Healthc… (show all)
are System (PVAHCS), requires the purchase of a Diasorin, Liaison XL analyzer. This requirement is for a one-time purchase for one (1) instrument for testing purposes only. There is a new separate services contract being implemented VISN wide that will cover the required QuantiFERON Gold Plus (QFT-G) Tuberculosis (TB) testing. This equipment must be able to use the supplies as-is from the OEM without modification. This will allow the PVAHCS test for TB on site and not have to send samples to a reference lab. This will provide a faster response time for continued veteran healthcare services. (See Attachment A - Statement of Work (SOW) herein for further details). Diasorin, Inc., is the only known source that is capable of providing the necessary equipment/instrument fully compatible with QuantiFERON Gold Plus (QFT-G) Tuberculosis (TB) testing. This procurement is being conducted using commercial item procedures pursuant to FAR Part 12 and FAR Part 13, specifically FAR Subpart13.106-1(b)(1)(i) allowing the Contracting Officer (CO) to solicit from one source. The North American Industry Classification System (NAICS) for this requirement is, 334516 Analytical Laboratory Instrument Manufacturing. Product/Service Code for this requirement is 6515 medical and surgical instruments, equipment, and supplies. The Small Business Administration (SBA) size standard for this sector is 1,000 employees. This notice of intent is neither a formal solicitation nor a request for competitive proposals. No solicitation document is available and telephone requests will not be honored. No award will be made on the basis of unsolicited quotations or offers received in response to this notice. Any response to this notice must show clear, compelling and convincing evidence that competition will be advantageous to the Government. The intent of this synopsis is for informational purposes only. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. A determination by the Government not to compete this action based on this notice is solely within the discretion of the Government. All inquiries and concerns must be addressed in writing via e-mail to Marcos Diaz at Marcos.Diaz@va.gov with the following information referenced in the subject line, 36C26225Q1188 Liaison XL Analyzer. A determination by the Government not to compete this proposed procurement based on the responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. All interested parties who are responsible, certified, and capable may identify their interest and may submit capability statement which shall be considered by the agency no later than 7:00 AM Pacific Time (PT) on July 21, 2025 to Marcos Diaz at Marcos.Diaz@va.gov. The interested parties bear full responsibility to ensure complete transmission and timely receipt. SDVOSB/VOSB respondents. If respondent is or SDVOSB or VOSB, respondent is encouraged to provide proof of https://veterans.certify.sba.gov certification. In addition, SDVOSB/VOSB Contractors are asked to acknowledge that they understand the limitations on sub-contracting pursuant to FAR clause 52.219-14, Limitations on Sub-Contracting, which will be included in the impending solicitation. Further SDVOSB/VOSB contractors are asked to respond that they are capable of providing the requested services keeping within the parameters of this clause. Please provide the information below: Company Name: UEI Number: Address: Point of Contact Name: Phone No: Email: Business size information Select all that applies: o Small Business o Emerging Small Business o Small Disadvantaged Business o Certified under Section 8(a) of the Small Business Act o HubZone o Woman Owned o Certified Service-Disabled Veteran Owned Small Business (registered in VetBiz.gov) o Veteran Owned Small Business (registered in VetBiz.gov) FSS/ GSA Contract Holder Yes No FSS/ GSA Contract Number Effective Date / Expiration Date NASA SEWP Contract Holder Yes No NASA SEWP Contract Number Effective Date / Expiration Date STATEMENT OF WORK DESCRIPTION/SPECIFICATIONS/STATEMENT OF WORK SCOPE OF PROCUREMENT: The desired instrumentation shall have the capability of performing or reporting the clinical parameters as defined within this statement of work. The instrument will be able to simultaneously perform the complete profile as described below and meet the performance characteristics for accuracy and precision as defined by the 1988 Clinical Laboratory Improvement Act (CLIA) and the Clinical and Laboratory Standards Institute (CLSI). Equipment shall maintain or preferably reduce the number of workstations or overall labor required to accomplish the required testing by each laboratory. If Contractor offers a family of analyzers, Phoenix VAMC technical evaluation panel will determine if instrumentation proposed meets needs of using facility. DEFINITIONS: Capital Equipment Purchase: Capital purchases, also known as capital expenditure or capex, are used to make a substantial investment in long-term fixed assets. This can include purchasing machinery and equipment, land, buildings or other infrastructure, and furniture and fixtures. For the purposes of this acquisition, the Liaison XL Analyzer is Capital Equipment. Business Associate Agreement (BAA) - A business associate is an entity, including an individual, company, or organization that, on behalf of VHA, performs or assists in the performance of functions or activities involving the use or disclosure of protected health information (PHI), or that provides certain services involving the disclosure of PHI. VHA is a covered entity under the HIPAA Privacy Rule. HIPAA regulations require VHA to execute HIPAA- compliant BAAs with certain entities that receives, uses, or discloses VHA PHI to perform some activity for VHA. These BAAs obligate VHA business associates to provide the same protections and safeguards to PHI that is required of VHA under the Privacy Rule. Parameter definitions High throughput immunoassay analyzer SALIENT CHARACTERISTICS AND GENERAL REQUIREMENTS TEST MENU: The capability of performing QuantiFERON Gold Plus (QFT-G) Tuberculosis (TB) testing QFT testing is FDA Cleared with the following characteristics: Primary screening Sample specimens Interferon gamma release assay (IGRA) General Requirements: Technical Features - The instrumentation shall be approved by the Food and Drug Administration (FDA) and shall have the following: Due to limited space, instrument dimensions must fit within the following: Footprint less than or equal to: 60 x 80 x 48 (W x H x D), dimensions in inches. Ability to monitor instrument performance. On board reagent inventory system. The vendor shall have the capability to provide limited carryover or disposable tips. Ready to use reagents allow Medical Laboratory Technicians in the operation and testing instead of Medical Technologists which helps relieve the impact on staffing. Ability to load sufficient reagents to complete a run, with the ability to load/add reagents while the instrument is running. On board reagent stability sufficient to accommodate both high volume (>100 per shift) and low volume (1 sample plus required controls per 24-hour period). Reagen
Who won similar work
10 award notices on SAM.gov in the last 24 months. Match: Same office, same NAICS 334516.
| Winner | Awards | Value | Last |
|---|---|---|---|
| BECKMAN COULTER, INC | 2 | $673K | Jan 6, 2026 |
| ABBOTT LABORATORIES INC. · $ABT | 1 | $9.1M | Jul 30, 2025 |
| ROCHE DIAGNOSTICS CORPORATION | 1 | $1.3M | Jun 17, 2025 |
| GOVERNMENT SCIENTIFIC SOURCE INC | 1 | $743K | Jul 7, 2026 |
| QUIDELORTHO SALES COMPANY · $QDEL | 1 | $522K | Sep 25, 2025 |
| AGILENT TECHNOLOGIES INC · $A | 1 | $436K | Apr 9, 2026 |
| STRIPES GLOBAL, INC. | 1 | $54K | Sep 4, 2025 |
| 10X GENOMICS, INC. · $TXG | 1 | $41K | Jul 7, 2026 |
| SOTERIX MEDICAL, INC. | 1 | $40K | May 19, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.
- Jul 7, 202610X GENOMICS, INC.$41KXenium Assay Kits
- Jul 7, 2026GOVERNMENT SCIENTIFIC SOURCE INC$743K6632--Tissue Processors for VISN 22
- May 19, 2026SOTERIX MEDICAL, INC.$40K6632--Waveform Generator
- Apr 9, 2026AGILENT TECHNOLOGIES INC$436K6640--Triple Quadrupole LC MS System
- Jan 6, 2026BECKMAN COULTER, INC$231K6550--BRIDGE: DXC800 Chemistry SystemCPT
- Sep 25, 2025QUIDELORTHO SALES COMPANY$522K6550--NOVATION Agreement Name Change Notice for: Bridge for Chemistry Immunochemistry System CPT
- Sep 4, 2025STRIPES GLOBAL, INC.$54K6640--OSMOMETER OsmoPRO Max
- Jul 30, 2025ABBOTT LABORATORIES INC.$9.1M6640--VA Phoenix Chemistry/IA CPT IDIQ
- Jun 17, 2025ROCHE DIAGNOSTICS CORPORATION$1.3MMolecular HPV PCR testing equipment - WHISE Grant
- Jan 29, 2025BECKMAN COULTER, INC$441K6550--DXC800 Chemistry System CPT
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 1 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (5 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $48K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 5 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.
- 4 of the past winners are listed companies
- 0 insider buys and 6 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.